Mangoceuticals (MGRX) Total Non-Current Liabilities (2022 - 2026)

Mangoceuticals has disclosed Total Non-Current Liabilities across 4 years of filings, most recently posting $250906.0 for Q2 2026.

• In Q2 2026, Total Non-Current Liabilities changed N/A year-over-year to $250906.0; the TTM figure through Jun 2026 stood at $250906.0 (changed N/A YoY), while the FY2023 annual figure was $64961.0, down 49.52% from the prior year.
• Total Non-Current Liabilities came in at $250906.0 for Q2 2026 at Mangoceuticals, up from $236965.0 in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $250906.0 in Q2 2026 to a low of $12167.0 in Q3 2024.
• Average Total Non-Current Liabilities over 4 years is $106367.5, with a median of $89449.5 recorded in 2023.
• Year-over-year, Total Non-Current Liabilities tumbled 49.52% in 2023 and sank 85.07% in 2024.
• Over 4 years, Total Non-Current Liabilities stood at $128680.0 in 2022, then plunged by 49.52% to $64961.0 in 2023, then slumped by 81.27% to $12167.0 in 2024, then soared by 1962.18% to $250906.0 in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $250906.0 in Q2 2026, $236965.0 in Q1 2026, and $12167.0 in Q3 2024.